Stanford Researchers Develop Compact Gene Activation Tool

Stanford Medicine scientists have created TIGRa, an ultracompact gene activation tool significantly smaller than existing CRISPR systems. This innovation addresses a key limitation of current gene-editing technologies by allowing easier delivery into cells. The tool offers substantial potential for precisely adjusting gene expression to treat and prevent various diseases, marking a significant step in gene therapy.